Rigel Announces Conference Call and Webcast to Report Second Quarter 2023 Financial Results and Business Update

Rhea-AI Summary

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) will report its Q2 2023 financial results on August 1, 2023, after market close. A live conference call and webcast will follow the announcement to discuss the financial results and provide a business update. Participants can access the call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The webcast will be available on the company's website and can be replayed for 90 days.

SOUTH SAN FRANCISCO, Calif., July 25, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its second quarter 2023 financial results after market close on Tuesday, August 1, 2023. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.

Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay for 90 days after the call via the Rigel website.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.

Contact for Investors & Media

Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com 

Media:
David Rosen
Argot Partners
Phone: 212.600.1902
Email: david.rosen@argotpartners.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2023-financial-results-and-business-update-301884462.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

When will Rigel Pharmaceuticals report its Q2 2023 financial results?

Rigel Pharmaceuticals will report its Q2 2023 financial results on August 1, 2023, after market close.

What will be discussed during the conference call and webcast?

The conference call and webcast will discuss the financial results of Rigel Pharmaceuticals for Q2 2023 and provide a business update.

How can participants access the live conference call?

Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international).

Where can the webcast be accessed?

The webcast can be accessed from the Investor Relations section of Rigel Pharmaceuticals' website at www.rigel.com.

How long will the webcast be available for replay?

The webcast will be available for replay for 90 days after the call via the Rigel Pharmaceuticals website.